CNOverview
iGeneTech, leveraging its independently developed BisCap® methylation capture sequencing technology, proudly introduces the BisCap® Multi-Cancer Early Detection Panel. This pre-defined methylation capture probe product features a target area of 27.7 kb, comprehensively covering the methylation regions associated with the early screening of eight major cancer types, including colorectal cancer, lung cancer, prostate cancer, ovarian cancer, pancreatic cancer, gastric cancer, liver cancer, and esophageal cancer. Designed to facilitate clinical non-invasive multiple cancer early detection.
